Susanne Kohout, the Country President and Managing Director of our EuroNeurotrophin Partner Organisation, Novartis (Hellas) S.A.C.I. in Greece held an interview with Fortune Greece on Novartis’ mission to help people live longer and better.
In the interview, Susanne Kohout tells us about her background and the development of the organisation and its strong position in the global market and how it got there. She also raises the concerns and challenges the COVID-19 pandemic has brought to Greece and the company itself and how they are handling this situation.
The full article is available to read online on fortunegreece.com
Novartis is ranked amongst one of the companies most heavily investing in R&D globally and we are happy to have them involved in the EuroNeurotrophin Project.